Trial Profile
A phase I trial to to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CKD-506 in single ascending dose and multiple ascending dose in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Nov 2018
Price :
$35
*
At a glance
- Drugs CKD 506 (Primary)
- Indications Inflammatory bowel diseases; Rheumatoid arthritis
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- 24 Oct 2018 Status changed to completed.
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 22 Dec 2017 New trial record